Nageswara Rao Kollu

Company: Apellis Pharmaceuticals

Job title: Senior Director

Seminars:

Promoting How Gene Editing Has Fast-Tracked Novel Therapies for Complement-Driven Diseases 9:45 am

Explore the rationale behind developing gene therapy strategies including durability and convenience Understand the strategies available to develop gene therapies ranging from AAVmediated gene editing, first to third generation CRISPR gene editing therapies and epigenetic editors Emphasize how compared to these other available gene therapy strategies, why base editing technology is important and how base…Read more

day: Day Two